“How Are We Going to Be Able to Pull That Off?”: Staff Perspectives on the Early Implementation of Mobile Medication Units in New York State

Miller M, Song M, Bessler A, Ruelas-Vargas K, Frank D, Harris SH, Gibbons JB, Jordan AE, Krawczyk, Saloner B - Addiction Science & Clinical Practice

  • Price, Value, and Access

Summary:

Interviews with 16 staff from four opioid treatment programs that launched mobile methadone units found implementation was slowed by inconsistent DEA guidance, vehicle maintenance and parking requirements, workforce shortages, community opposition, and lower-than-expected patient demand. Persistent leadership, sustained state funding, and strong cross-program partnerships helped get units running, suggesting that the potential of mobile units to expand methadone access depends on these factors.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty

Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open

  • Price, Value, and Access